Overview
No overview information available.
Indication
⑴用于在有慢性心力衰竭(NYHA类别II-IV)患者中减低对心力衰竭的心血管死亡及住院治疗慢性心力衰竭和射血分数降低。本品通常与其他心力衰竭治疗结合，代替一种ACE抑制药或其他血管紧张素II受体阻断药。 ⑵用于治疗原发性高血压.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/04/08 | Phase 4 | Not yet recruiting | China National Center for Cardiovascular Diseases | ||
2024/12/04 | Phase 3 | Not yet recruiting | |||
2024/11/18 | Phase 3 | Recruiting | |||
2024/07/15 | Phase 4 | Not yet recruiting | |||
2024/02/22 | Phase 1 | Not yet recruiting | |||
2024/02/20 | Phase 1 | Not yet recruiting | |||
2024/01/23 | Phase 4 | Recruiting | |||
2024/01/05 | Phase 1 | Not yet recruiting | Dr. Reddy's Laboratories (Thailand) Limited | ||
2023/11/28 | Phase 3 | Completed | |||
2023/11/21 | Phase 2 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Sacubitril Valsartan Sodium Tablets | 国药准字H20243656 | 化学药品 | 片剂 | 4/30/2024 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20253014 | 化学药品 | 片剂 | 1/2/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20253081 | 化学药品 | 片剂 | 1/8/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20253444 | 化学药品 | 片剂 | 2/25/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20253445 | 化学药品 | 片剂 | 2/25/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20249413 | 化学药品 | 片剂 | 11/15/2024 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20258061 | 化学药品 | 片剂 | 4/9/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20253790 | 化学药品 | 片剂 | 4/1/2025 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字HJ20170363 | 化学药品 | 片剂 | 12/20/2021 | |
| Sacubitril Valsartan Sodium Tablets | 国药准字H20254029 | 化学药品 | 片剂 | 4/30/2025 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.